These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 743362)

  • 1. [Preliminary pharmacologic trials of new phenylbutazone esters].
    Sugawara SH; Oga S; Yasaka WJ; Santoro MI
    Boll Chim Farm; 1978 Feb; 117(2):90-101. PubMed ID: 743362
    [No Abstract]   [Full Text] [Related]  

  • 2. The preparation and pharmacological selection of a new anti-inflammatory agent, thiazolinobutazone.
    Moragues J; Thiele K; Márquez M; Colombo M; Roberts DJ
    Arzneimittelforschung; 1974 Nov; 24(11):1785-6. PubMed ID: 4480049
    [No Abstract]   [Full Text] [Related]  

  • 3. New phenylbutazone esters: synthesis and some pharmacological properties.
    Stacchino C; Spano' R; Pettiti A
    Boll Chim Farm; 1983 Apr; 122(4):186-9. PubMed ID: 6615645
    [No Abstract]   [Full Text] [Related]  

  • 4. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
    Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
    [No Abstract]   [Full Text] [Related]  

  • 5. General pharmacological properties of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol (ditazol).
    Caprino L; Borrelli F; Falchetti R
    Arzneimittelforschung; 1973 Sep; 23(9):1283-7. PubMed ID: 4801221
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological and toxicological studies with 1-benzyl-3-(2,3-dihydroxypropoxy)indazole.
    Propker M; Pongracz MJ; Szabo JL
    Arzneimittelforschung; 1976; 26(7):1393-7. PubMed ID: 1087562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 7. Pharmacological comparison with standard anti-inflammatory drugs.
    Marazzi-Uberti E; Lumachi B; Gaetani M; Coppi G; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:213-6. PubMed ID: 5067195
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-(2,4-dichlorophenoxy) phenylacetic acid (fenclofenac): one of a novel series of anti-inflammatory compounds with low ulcerogenic potential.
    Atkinson DC; Godfrey KE; Jordan BJ; Leach EC; Meek B; Nichols JD; Saville JF
    J Pharm Pharmacol; 1974 May; 26(5):357-8. PubMed ID: 4153166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxicity and collateral pharmacological effects of A 3: a new non-steroid anti-inflammatory agent].
    Chieli T; Fregnan GB; Frigerio L; Vidali M
    Boll Chim Farm; 1976 Jan; 115(1):41-57. PubMed ID: 1275978
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adrenalectomy and medullectomy in experimental phenylbutazone induced ulcers. Preliminary note].
    Bucciarelli G; Biliotti G; Andreoli F; Stefani P; Masi C; Pagliai P; Crisci C
    Arch De Vecchi Anat Patol; 1968 Dec; 54(1):91-7. PubMed ID: 5744091
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats.
    Cioli V; Putzolu S; Rossi V; Scorza Barcellona P; Corradino C
    Toxicol Appl Pharmacol; 1979 Sep; 50(2):283-9. PubMed ID: 505458
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of feprazone and phenylbutazone interaction with warfarin in man.
    Chierichetti S; Bianchi G; Cerri B
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):568-72. PubMed ID: 810317
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of restraint and phenylbutazone on jejunal mucosa implanted in the rat stomach].
    Lambert R; André C; Descos F
    C R Seances Soc Biol Fil; 1970; 164(7):1497-500. PubMed ID: 4252614
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability and anti-inflammatory effects of phenylbutazone sodium and phenylbutazone calcium in rats.
    Hanada S; Mengardo S; Oga S
    Boll Chim Farm; 1987 May; 126(5):203-7. PubMed ID: 3450309
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological investigations of benzothiazoline derivatives.
    Takashima T; Kado Y; Kumada S
    Arzneimittelforschung; 1972 Apr; 22(4):711-5. PubMed ID: 5068252
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological properties of the antiinflammatory agent 10-methylamine-11-H-indeno-[1,2-b]quinolin-11-one (MB432).
    Chojnacka-Wójcik E; Naparzewska A
    Pol J Pharmacol Pharm; 1983; 35(4):327-32. PubMed ID: 6607462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of thiazolinobutazone (LAS 11 871). III. General pharmacology, ulcerogenic effects and acute toxicity.
    Colombo M; Márquez M; Roberts DJ
    Arzneimittelforschung; 1976; 26(7):1347-56. PubMed ID: 1036923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology, toxicology and pharmacokinetics of mofebutazone].
    Loew D; Schuster O; Knoell HE; Graul EH
    Z Rheumatol; 1985; 44(4):186-92. PubMed ID: 4050150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and pharmacological investigations on 2H-pyridazino[4,5-b] [1,4]benzothiazin-1(10H)-one derivatives.
    Vittorio F; Pappalardo MS; Ronsisvalle G; Caruso A; Leone MG; Amico-Roxas M
    Farmaco; 1989 Oct; 44(10):911-32. PubMed ID: 2619858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.